Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + HAI + Systemic Chemo in Resected Hepatic Metastases From Colorectal Cancer
NCT00200200Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Nov 2004
- Primary completion
- Mar 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colorectal cancer (CRC), secondary malignant neoplasm of liver, sponsored by Memorial Sloan Kettering Cancer Center. Started Nov 2004; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)secondary malignant neoplasm of liver
Beyond the preview
Go deeper on NCT00200200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00200200.